OUR CLINICAL TRIALS
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients with Early-Stage Leer mas
A phase 3, multicenter, randomized, open-label, active-controlled study of trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine Leer mas
European cooperative study of primary systemic therapy in women with operable breast cancer and T Leer mas
A Phase III, multicenter, open-label study of ribociclib vs. palbociclib in patients with advanced hormone Leer mas